154 participants
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-11
- Start Date:
- 2018-03-16
- Completion:
- 2020-10-15
Conditions
- Urinary Bladder Neoplasms
Interventions
- DRUG